JPRN-UMIN000007430已完成未知
Additional therapy for the patients with early gastric cancer after endoscopic submucosal dissection - Additional therapy for the patients with early gastric cancer after endoscopic submucosal dissection
Digestive Disease Center, Showa University Northern Yokohama Hospital0 个研究点目标入组 150 人开始时间: 2012年3月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) synchronous or metachronous malignancy
研究者
相似试验
撤回
1 期
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersClinical Stage I Gastric Cancer AJCC v8Clinical Stage II Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8Gastric AdenocarcinomaClinical Stage IIA Gastric Cancer AJCC v8Clinical Stage IIB Gastric Cancer AJCC v8Pathologic Stage II Gastric Cancer AJCC v8Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IB Gastric Cancer AJCC v8Pathologic Stage IIA Gastric Cancer AJCC v8Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IIB Gastric Cancer AJCC v8Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage III Gastric Cancer AJCC v8Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IIIA Gastric Cancer AJCC v8Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IIIB Gastric Cancer AJCC v8Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IIIC Gastric Cancer AJCC v8Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8NCT05296005Ohio State University Comprehensive Cancer Center20
招募中
1 期
CAR-T-cell treatment for untreated high risk MANtle Cell LymphomaMantle Cell Lymphoma (MCL)MedDRA version: 21.0Level: PTClassification code: 10026805Term: Mantle cell lymphoma stage IV Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026803Term: Mantle cell lymphoma stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026804Term: Mantle cell lymphoma stage III Class: 100000004864CTIS2022-502405-15-01Klinikum Der Universitat Munchen AöR91
已完成
不适用
Oxygen therapy for treating patients with residual sleep apnoea following upper airway surgeryObstructive Sleep ApnoeaRespiratory - Sleep apnoeaSurgery - Other surgeryACTRN12617001361392Monash Health20
已完成
不适用
Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX)ndifferentiated arthritis, probable rheumatoid arthritis according to ACR-1958 criteriaMusculoskeletal DiseasesOther arthrosisISRCTN21334657eiden University Medical Center (LUMC) (Netherlands)110
进行中（未招募）
1 期
Greater occipital nerve block for a sooner en and better treatment of cluster headacheEpisodic cluster headacheEUCTR2018-002224-17-NLeids Universitair Medisch Centrum80